Seiichiro Mine
Overview
Explore the profile of Seiichiro Mine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li S, Yoshida Y, Kobayashi E, Kubota M, Matsutani T, Mine S, et al.
Sci Rep
. 2021 Jun;
11(1):13450.
PMID: 34188129
Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant...
12.
Hiwasa T, Wang H, Goto K, Mine S, Machida T, Kobayashi E, et al.
BMC Med
. 2021 Jun;
19(1):131.
PMID: 34103026
Background: Acute ischemic stroke (AIS) is a serious cause of mortality and disability. AIS is a serious cause of mortality and disability. Early diagnosis of atherosclerosis, which is the major...
13.
Ozawa A, Yamazaki M, Toda Y, Ebata T, Mine S, Kimura K
Rinsho Shinkeigaku
. 2021 May;
61(6):407-408.
PMID: 34024888
No abstract available.
14.
Li S, Yoshida Y, Kobayashi E, Adachi A, Hirono S, Matsutani T, et al.
Int J Mol Med
. 2020 Sep;
46(4):1274-1288.
PMID: 32945427
The aim of the present study was to identify novel antibody markers for the early diagnosis of atherosclerosis in order to improve the prognosis of patients at risk for acute...
15.
Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y, et al.
Cancer Sci
. 2020 Sep;
111(12):4453-4464.
PMID: 32939876
Some cancers are related to atherosclerotic diseases; therefore, these two types of disease may share some antibody biomarkers in common. To investigate this, a first screening of sera was performed...
16.
Yoshida Y, Zhang X, Wang H, Machida T, Mine S, Kobayashi E, et al.
Heliyon
. 2020 Sep;
6(8):e04661.
PMID: 32904265
Background: Serum antibody markers have been increasingly identified not only for cancer and autoimmune diseases but also for atherosclerosis-related diseases such as acute ischemic stroke (AIS), acute myocardial infarction (AMI),...
17.
Ozawa A, Yamazaki M, Toda Y, Ebata T, Mine S, Kimura K
Rinsho Shinkeigaku
. 2019 Dec;
60(1):32-36.
PMID: 31852867
Epilepsy surgery for patients with drug-resistant epilepsy after anti-N-methyl-D-aspartate (NMDA) receptor encephalitis has been rarely reported. The present study reports two patients with anti-NMDA receptor encephalitis, who later underwent epilepsy...
18.
Yoshida Y, Hiwasa T, Machida T, Kobayashi E, Mine S, Matsushima J, et al.
Neurol Med Chir (Tokyo)
. 2018 Jun;
58(7):303-310.
PMID: 29848906
Recent clinical research has revealed a significant correlation between atherosclerosis, one of the primary etiologies of ischemic stroke, and the immune system. Assuming that "disease-specific autoantibodies are produced in the...
19.
Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, et al.
Oncotarget
. 2018 Mar;
9(10):8836-8848.
PMID: 29507658
Background: Disease specific autoantibodies have been detected in the sera of patients with atherosclerosis-related diseases, such as cerebral infarction, cardiovascular disease. In the present study, we aimed to identify novel...
20.
Wang H, Zhang X, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, et al.
Oncotarget
. 2018 Feb;
9(5):5600-5613.
PMID: 29464021
Transient ischemic attack (TIA) is a predictor for cerebral infarction (CI), and early diagnosis of TIA is extremely important for the prevention of CI. We set out to identify novel...